An entirely new way of manufacturing pharmaceutical and other valuable chemicals

Historically, pharmaceutical industries have relied on novel medications to meet profit targets; however in today's competitive markets, the huge expenditures associated with drug development now challenge this approach. An international team led by A*STAR researchers show how manufacturers can make rapid decisions about switching to alternative drug manufacturing procedures with promising economic prospects.

Read the whole article on Physorg

More from Physorg